Longer-term follow-up data from CARTITUDE-1 study show an overall response rate of 100% while 86% experienced a complete […]

The treatment could benefit 500 people with follicular lymphoma

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Updated Date: Wed, 06 May 2020 00:00:00 EDT

Back in January, Merck said Keytruda—its anti-PD-1 therapy—had missed the mark in small cell lung cancer, an area […]

Pfizer and Astellas’ Xtandi is already approved to treat non-metastatic castration-resistant prostate cancer, thanks to data showing it […]

The medical research world is responding to the covid-19 pandemic at breathtaking speed. There has been a maelstrom […]